NFS1 and colorectal cancer: Lin et al. revealed that the loss of NFS1 significantly enhanced the sensitivity of colorectal cancer cells to oxaliplatin, and that NFS1 deficiency, when combined with oxaliplatin, triggered PANoptosis by increasing intracellular levels of reactive oxygen species (ROS) [17].